Trial Profile
Mechanisms of Belatacept (Nulojix) Effect on Alloimmunity and Antiviral Response After Kidney Transplantation - (BMS Study# IM 103-309)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 21 Apr 2021 Status changed from active, no longer recruiting to completed.
- 26 Aug 2020 Planned End Date changed from 1 Jul 2020 to 1 Dec 2020.
- 26 Aug 2020 Planned primary completion date changed from 1 Jun 2020 to 1 Dec 2020.